Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Safety of Xeloda in Solid Tumours
- Status
- COMPLETED
- Phase
- N/A
Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca.
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2